STOCK TITAN

Valaris Limited 10-Q Filings

VAL NYSE

Every 10-Q that Valaris Limited (VAL) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 10-Q covers the quarterly report filed between annual reports, so if you follow VAL and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full VAL filings page.

Rhea-AI Summary

Valaris Limited reported Q2 2026 total operating revenues of $539.2 million, down from $615.2 million a year earlier, and net income attributable to Valaris of $50.4 million versus $115.1 million. For the first six months, revenues were $1,004.6 million and net income attributable to Valaris was $34.0 million, compared with $1,235.9 million and $77.2 million in the prior-year period. Diluted EPS was $0.72 for the quarter and $0.48 year‑to‑date.

Operating income was $51.1 million for the quarter and $71.1 million year‑to‑date, while net cash provided by operating activities declined to $88.1 million from $275.9 million in the first half of 2025. Results included $25.0 million of merger and integration expenses related to a pending all‑stock business combination with Transocean, under which each Valaris share would be exchanged for 15.235 Transocean shares, and Valaris could owe a $173.0 million termination fee in certain circumstances. Management estimates conflicts in the Middle East reduced operating income by approximately $30.0 million in the quarter and $38.0 million year‑to‑date.

As of June 30 2026, cash and cash equivalents and restricted cash totaled $558.0 million, against $1,087.6 million of 2030 Second Lien Notes, with no borrowings under the $375.0 million 2028 revolving credit facility. Contract backlog was $4,585.2 million for Valaris and $1,834.1 million for ARO as of early August 2026.

Rhea-AI Summary

Valaris Limited reported a Q1 2026 net loss of $16.4 million (loss per share $0.24), narrowing from a $37.9 million loss a year earlier. Total operating revenues fell to $465.4 million from $620.7 million, mainly due to fewer operating days for floater rigs and the sale or retirement of several units.

Operating income dropped to $20.0 million from $143.0 million, reflecting lower floater activity and $13.6 million of merger and integration expenses tied to a pending all‑stock business combination with Transocean. Equity in earnings of ARO improved to $6.8 million from $2.6 million, and cash from operations was $75.0 million versus $155.9 million a year earlier.

As of March 31, 2026, Valaris had total assets of $5.36 billion, shareholders’ equity of $3.16 billion, long‑term debt of $1.09 billion in 2030 Second Lien Notes and $595.4 million of cash and restricted cash. Contract backlog reached $4.93 billion for Valaris and $1.92 billion for ARO as of May 4, 2026, supported by strong drillship and jackup demand.

Rhea-AI Summary

Valaris Limited reported quarterly results for the period ended September 30, 2025. Total operating revenues were $595.7 million versus $643.1 million a year ago, while operating income rose to $130.5 million from $94.9 million as contract drilling expenses declined. Net income attributable to Valaris increased to $188.1 million from $64.6 million, and diluted EPS was $2.65 compared with $0.88.

Results benefited from $87.7 million in Other, net and lower general and administrative costs. The ARO joint venture contributed equity earnings of $4.4 million versus a loss in the prior year period. The company recorded no impairment this quarter, with year‑to‑date impairment at $7.8 million related to earlier semisub retirements.

Cash and cash equivalents were $662.7 million as of September 30, 2025, up from $368.2 million at year‑end, with long‑term debt at $1,085.2 million. Year‑to‑date operating cash flow was $474.0 million. Notable asset sales included VALARIS 247, generating an $88.4 million pre‑tax gain. The company repurchased $75.0 million of shares in the quarter. Common shares outstanding were 69,577,278 as of October 23, 2025.